Sandbox vidit: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 80: | Line 80: | ||
|} | |} | ||
==Long term management of atrial flutter== | ===Long term management of atrial flutter=== | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
Line 91: | Line 91: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''First episode and well-tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Cardioversion alone''''' <br> or <br> ▸ '''''Catheter ablation''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''First episode and well-tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Cardioversion alone''''' <br> or <br> ▸ '''''Catheter ablation''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Recurrent and well-tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Catheter ablation'''''<br> or <br>▸ '''''Dofetilide'''''<br> or <br>▸ '''''Amiodarone <br>or<br> | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Recurrent and well-tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Catheter ablation'''''<br> or <br>▸ '''''Dofetilide'''''<br> or <br>▸ '''''Amiodarone <br>or<br> Sotalol <br>or<br> Flecainide <br>or<br> Quinidine <br>or<br> Propafenone <br>or<br> Procainamide <br>or<br> Disopyramide''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Poorly tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Catheter ablation''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Poorly tolerated atrial flutter''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Catheter ablation''''' |
Revision as of 19:04, 10 March 2014
Atrial flutter | |||||||||||||||||||||||||||||||||||||||
Unstable | Stable | ||||||||||||||||||||||||||||||||||||||
❑ Look for the presence of any of these:
| ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours ❑ Administer rate control therapy (AV nodal blockers) THEN ❑ Attempt conversion
| ||||||||||||||||||||||||||||||||||||||
❑ Assess need for therapy to prevent recurrence | |||||||||||||||||||||||||||||||||||||||
❑ Administer antiarrythmic therapy to prevent recurrences
❑ Consider catheter ablation if antiarrhythmic therapy fails | |||||||||||||||||||||||||||||||||||||||
Anticoagulation Therapy
Shown below are tables depicting the assessment of risk of stroke and the appropriate anticoagulation therapy among patients with Atrial flutter.[1]
|
Low Risk Factors | Moderate Risk Factors | High Risk Factors |
▸ Female gender ▸ Age 65-74 years ▸ Coronary artery disease ▸ Thyrotoxicosis |
▸ Age ≥ 75 years ▸ Hypertension ▸ Heart failure ▸ LV ejection fraction ≤ 35% ▸ Diabetes mellitus |
▸ Previous stroke, TIA or embolism ▸ Mitral stenosis ▸ Prosthetic heart valve |
Acute management of atrial flutter
|
Long term management of atrial flutter
|
- ↑ Fuster, V.; Rydén, LE.; Cannom, DS.; Crijns, HJ.; Curtis, AB.; Ellenbogen, KA.; Halperin, JL.; Kay, GN.; Le Huezey, JY. (2011). "2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 123 (10): e269–367. doi:10.1161/CIR.0b013e318214876d. PMID 21382897. Unknown parameter
|month=
ignored (help)